表紙：前臨床CRO市場規模、シェア、成長分析、サービス別、モデル別、用途別、エンドユーザー別、地域別 - 産業予測 2025年～2032年

市場調査レポート

商品コード

1736972

前臨床CRO市場規模、シェア、成長分析、サービス別、モデル別、用途別、エンドユーザー別、地域別 - 産業予測 2025年～2032年

Preclinical CRO Market Size, Share, and Growth Analysis, By Service, By Model (Patient-Derived Organoid Model, Patient-Derived Xenograft Model), By Application, By End User, By Region - Industry Forecast 2025-2032

出版日: 2025年05月22日
発行: SkyQuest
ページ情報: 英文 175 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 767,228円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 897,512円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,027,796円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.76円

全表示
概要
目次

概要

サンプル依頼リストに入れる

前臨床CROの世界市場規模は、2023年に64億米ドルと評価され、2024年の70億1,000万米ドルから2032年には146億米ドルに成長し、予測期間中（2025-2032年）のCAGRは9.6％で成長する見通しです。

世界の前臨床試験受託機関（CRO）市場の成長は、契約ベースでCROサービスを活用するバイオ製薬企業、医療機器企業、政府研究機関の関与の増加によって大きく後押しされています。慢性疾患や遺伝子関連疾患の急増により、これらの企業は、効果的な診断や治療のための革新的な医薬品や機器の開発を目的とした研究に多額の投資を必要としています。前臨床CROは、必要不可欠な研究開発ソリューションを提供することで、これらの企業が中核的な活動に集中できるようにし、医薬品や機器の開発プロセスを合理化します。さらに、新しい救命治療に対する緊急の需要が前臨床研究への投資を促進し、医薬品開発と商業化戦略におけるCROの重要な役割を確固たるものにしています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024年）

主要企業プロファイル

Charles River Laboratories International, Inc.（USA）
Labcorp Drug Development（USA）
Eurofins Scientific（Luxembourg）
ICON plc（Ireland）
IQVIA（USA）
Parexel International Corporation（USA）
PPD（USA）
Syneos Health（USA）
Crown Bioscience（USA）
Envigo（USA）
Intertek Group plc（UK）
SGS SA（Switzerland）
MPI Research（USA）
Worldwide Clinical Trials（USA）
Inotiv, Inc.（USA）
Jubilant Biosys Ltd.（India）

結論と提言

Product Code: SQMIG35D2298

Global Preclinical CRO Market size was valued at USD 6.4 billion in 2023 and is poised to grow from USD 7.01 billion in 2024 to USD 14.6 billion by 2032, growing at a CAGR of 9.6% during the forecast period (2025-2032).

The growth of the global preclinical contract research organization (CRO) market is significantly fueled by the increasing engagement of biopharmaceutical companies, medical device firms, and government research agencies, who leverage CRO services on a contractual basis. The surge in chronic and gene-related diseases necessitates substantial investment from these companies in research aimed at the development of innovative drugs and devices for effective diagnosis and treatment. Preclinical CROs enable these organizations to concentrate on core activities by providing essential research and development solutions, thereby streamlining the drug and device creation process. Additionally, the urgent demand for new life-saving therapies is propelling investments in preclinical research, solidifying the crucial role of CROs in drug development and commercialization strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Preclinical CRO market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Preclinical CRO Market Segments Analysis

Global Preclinical CRO Market is segmented by Service, Model, Application, End User and region. Based on Service, the market is segmented into Bioanalysis and DMPK studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology and Others. Based on Model, the market is segmented into Patient-Derived Organoid (PDO) Model and Patient-Derived Xenograft Model. Based on Application, the market is segmented into Oncology, Neurology, Cardiology, Infectious Diseases, Metabolic Disorders and Others. Based on End User, the market is segmented into Pharmaceutical and Biotechnological Companies, Government and Academic Institutes, Medical Device Companies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Preclinical CRO Market

A significant catalyst for the growth of the global preclinical Contract Research Organization (CRO) market is the swift expansion of the biopharmaceutical industry. As biopharmaceutical companies increasingly venture into the development of innovative drugs, they are turning to CROs to manage essential preclinical testing activities, including drug efficacy evaluations and toxicity assessments. This growing reliance on outsourcing preclinical research functions not only enhances efficiency but also allows biopharma firms to focus on their core competencies. Consequently, the demand for preclinical CRO services is anticipated to rise substantially in the future, driven by this ongoing trend in the industry.

Restraints in the Global Preclinical CRO Market

One significant restraint in the Global Preclinical CRO market is the potential loss of management control during the development process when outsourcing preclinical testing. Biopharmaceutical companies that engage third-party CROs may find themselves with diminished oversight of their research activities. This dependency can hinder progress, as it may lead to delays, miscommunication, and inconsistent results. Consequently, a lack of direct management can restrict innovation and efficiency, ultimately affecting the overall success of drug development projects. These challenges underline the importance of careful selection and communication when collaborating with contract research organizations.

Market Trends of the Global Preclinical CRO Market

The Global Preclinical Contract Research Organization (CRO) market is experiencing a significant trend toward the integration of automation and artificial intelligence (AI), revolutionizing research operations. This transformation facilitates faster and more accurate outcomes, allowing for optimized data processing and predictive modeling in drug development. As AI-driven solutions become widespread, they not only enhance efficiency but also significantly reduce time and costs associated with preclinical studies. This trend underscores a broader shift within the industry towards embracing cutting-edge technologies, indicating that the market is poised for continued growth and innovation as organizations increasingly leverage these advancements to streamline their operations and improve research productivity.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Preclinical CRO Market Size by Service & CAGR (2025-2032)

Market Overview
Bioanalysis and DMPK studies
- In vitro ADME
- In-vivo PK
Toxicology Testing
- GLP
- Non-GLP
Compound Management
- Process R&D
- Custom Synthesis
- Others
Chemistry
- Medicinal Chemistry
- Computation Chemistry
Safety Pharmacology
Others

Global Preclinical CRO Market Size by Model & CAGR (2025-2032)

Market Overview
Patient-Derived Organoid (PDO) Model
Patient-Derived Xenograft Model

Global Preclinical CRO Market Size by Application & CAGR (2025-2032)

Market Overview
Oncology
Neurology
Cardiology
Infectious Diseases
Metabolic Disorders
Others

Global Preclinical CRO Market Size by End User & CAGR (2025-2032)

Market Overview
Pharmaceutical and Biotechnological Companies
Government and Academic Institutes
Medical Device Companies
Others

Global Preclinical CRO Market Size & CAGR (2025-2032)

North America (Service, Model, Application, End User)
- US
- Canada
Europe (Service, Model, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Service, Model, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Service, Model, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Service, Model, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Charles River Laboratories International, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Labcorp Drug Development (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IQVIA (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Parexel International Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PPD (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syneos Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Crown Bioscience (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Envigo (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intertek Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGS SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MPI Research (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Worldwide Clinical Trials (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inotiv, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jubilant Biosys Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

前臨床CRO市場規模、シェア、成長分析、サービス別、モデル別、用途別、エンドユーザー別、地域別 - 産業予測 2025年～2032年

Preclinical CRO Market Size, Share, and Growth Analysis, By Service, By Model (Patient-Derived Organoid Model, Patient-Derived Xenograft Model), By Application, By End User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

前臨床CRO市場規模：サービス別& CAGR（2025-2032）

前臨床CRO市場規模：モデル別& CAGR（2025-2032）

前臨床CRO市場規模：用途別& CAGR（2025-2032）

前臨床CRO市場規模：エンドユーザー別& CAGR（2025-2032）

前臨床CRO市場規模& CAGR（2025-2032）